Phase II study of weekly 4'-epidoxorubicin in patients with metastatic adenocarcinoma of the cervix: an EORTC Gynaecological Cancer Cooperative Group study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples